---
title: Cell-Easy vs Omniabio
slug_a: cell-easy
slug_b: omniabio
site: cdmo
review_signal_gate: closed
canonical_path: /compare/cell-easy/omniabio
---

# Cell-Easy vs Omniabio

Side-by-side profile data from each company listing on this directory.

## Cell-Easy

- Profile: [/companies/cell-easy](/companies/cell-easy)

Cell-Easy — Cell-Easy is a CDMO specializing in development and GMP manufacturing of cell therapies, with expertise across T cells, NK cells, MSCs, and iPSCs. The company has manufactured over 1,000 clinical doses and supports 50+ development programs from process optimization through regulatory compliance.

Services: 6. Modalities: 1. Indications: 2. Locations: 1. Certifications: 0. The strongest documented coverage currently appears in services (6).

### Services

- Cell-Line Development
- Cell Therapy Manufacturing
- Autologous Cell Therapy Manufacturing
- Allogeneic Cell Therapy Manufacturing
- Process Development
- CMC Analytical Development

### Modalities

- Cell Therapy

### Development capabilities

- Analytical method development
- Cell line development

### Manufacturing capabilities

- Drug Substance (DS)
- Drug Product (DP)

## Omniabio

- Profile: [/companies/omniabio](/companies/omniabio)

Omniabio — OmniaBio is a cell and gene therapy CDMO specializing in process development, analytical development, and GMP manufacturing for lentiviral vectors, iPSCs, and immune cell-based therapies. The company operates a 120,000 sq ft facility in Hamilton, Ontario, integrating AI, automation, and robotics to deliver scalable manufacturing from preclinical to commercial stages.

Services: 8. Modalities: 2. Indications: 0. Locations: 1. Certifications: 0. The strongest documented coverage currently appears in services (8).

### Services

- Cell-Line Development
- Lentiviral Vector Manufacturing
- Cell Therapy Manufacturing
- Autologous Cell Therapy Manufacturing
- Allogeneic Cell Therapy Manufacturing
- Process Development
- CMC Analytical Development
- CMC Regulatory Submission Support

### Modalities

- Cell Therapy
- Gene Therapy

### Development capabilities

- Analytical method development
- Cell line development

### Manufacturing capabilities

- Drug Substance (DS)
- Drug Product (DP)